<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03006770</url>
  </required_header>
  <id_info>
    <org_study_id>PLX-CLI-03</org_study_id>
    <nct_id>NCT03006770</nct_id>
  </id_info>
  <brief_title>Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization</brief_title>
  <official_title>Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pluristem Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pluristem Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a randomized, placebo-controlled, parallel group, multicenter, Phase III&#xD;
      study.The study aims to evaluate the Efficacy, Tolerability and Safety of Intramuscular&#xD;
      Injections of PLX PAD for the Treatment of Subjects with Critical Limb Ischemia (CLI) with&#xD;
      Minor Tissue Loss (Rutherford Category 5) who are Unsuitable for Revascularization.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 22, 2017</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to major amputation or death (AFS)</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first occurrence of any of the events (in index leg)-major amputation, revascularization due to worsening of CLI, All-cause mortality.</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to major amputation of the index leg.</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in ischemic pain as assessed by numerical rating scale (NRS) at 6 months.</measure>
    <time_frame>6 months from enrollment</time_frame>
    <description>NRS measures the intensity or magnitude of sensations and subject feelings and the relative strength of attitudes and opinions about specific stimuli, on a scale of 0 to 10 with a score of zero denoting &quot;no pain at all&quot; and a score of 10 denoting &quot;worst possible pain&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with complete healing of all ischemic lesions i.e., ulcers and necroses in the index leg at 12 months.</measure>
    <time_frame>12 months from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time (days) from randomization to occurrence of death.</measure>
    <time_frame>Up to 36 months from enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">213</enrollment>
  <condition>Critical Limb Ischemia (CLI)</condition>
  <arm_group>
    <arm_group_label>PLX-PAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PLX-PAD will be administered via 30 IM injections (0.5 mL each). Each subject will be treated twice, with an interval of 8 weeks between treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be administered via 30 IM injections (0.5 mL each). Each subject will be treated twice, with an interval of 8 weeks between treatments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PLX-PAD</intervention_name>
    <description>Local intramuscular (IM) injections of PLX-PAD in the index leg.</description>
    <arm_group_label>PLX-PAD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Local intramuscular (IM) injections of Placebo in the index leg.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult male or female subjects between ages 45-99 years of age.&#xD;
&#xD;
          2. CLI, with minor tissue loss up to the ankle level (Rutherford Category 5)&#xD;
&#xD;
          3. Ankle pressure (AP) ≤70 mmHg or TP ≤50 mmHg in the index leg. (If a subject has ABI&#xD;
             &gt;1.4 and TP is not measureable, inclusion may be based on TcPO2 ≤30 mmHg)&#xD;
&#xD;
          4. Subject unsuitable for revascularization (by any method) in the index leg.&#xD;
&#xD;
          5. Ischemic lesions in the index leg stable for at least 2 weeks.&#xD;
&#xD;
          6. Ischemic ulcers in the index leg without tendon or bone exposure (unless secondary to&#xD;
             a minor amputation).&#xD;
&#xD;
          7. Under treatment for cardiovascular risk factors: hypertension, hyperlipidemia,&#xD;
             diabetes, in accordance with applicable guidelines. Concomitant therapy with a statin&#xD;
             and an anti-platelet agent for at least 2 weeks prior to randomization.&#xD;
&#xD;
          8. Women of childbearing potential must have a negative serum pregnancy test at screening&#xD;
             and must be willing to use at least one highly effective birth control method&#xD;
             throughout the study.&#xD;
&#xD;
          9. Subject understood, agreed and provided informed consent. Patients must give written&#xD;
             informed consent before any assessment is performed .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Non-atherosclerotic PAD (e.g. Buerger's disease).&#xD;
&#xD;
          2. CLI with major tissue loss (Rutherford Category 6) in either leg.&#xD;
&#xD;
          3. Evidence of active infection (e.g., cellulitis, osteomyelitis).&#xD;
&#xD;
          4. Subject having undergone surgical revascularization or major amputation less than 1&#xD;
             month prior to screening, or endovascular revascularization or minor amputation less&#xD;
             than 2 weeks prior to screening.&#xD;
&#xD;
          5. Planned or potential need for major/minor amputation or any revascularization within 1&#xD;
             month of study entry upon investigator's judgment.&#xD;
&#xD;
          6. Aorto-iliac stenosis or common femoral artery stenosis ≥70%, or otherwise suspicion of&#xD;
             inadequate inflow to the leg.&#xD;
&#xD;
          7. Life expectancy of less than 6 months.&#xD;
&#xD;
          8. Stroke or acute myocardial infarction/unstable angina within 3 months prior to&#xD;
             screening.&#xD;
&#xD;
          9. Severe congestive heart failure symptoms (New York Heart Association [NYHA] class&#xD;
             III-IV).&#xD;
&#xD;
         10. Uncontrolled severe hypertension.&#xD;
&#xD;
         11. Diabetes mellitus with HbA1c &gt;10%.&#xD;
&#xD;
         12. Current or history of proliferative retinopathy.&#xD;
&#xD;
         13. Known Hepatitis B virus or Hepatitis C virus or acquired immunodeficiency syndrome&#xD;
             (AIDS) infections.&#xD;
&#xD;
         14. Subjects with international normalized ratio (INR) &gt;2.&#xD;
&#xD;
         15. Subject on renal replacement therapy or planned to start renal replacement therapy&#xD;
             within 3 months of first screening visit.&#xD;
&#xD;
         16. Subject is currently enrolled in, or has not yet completed a period of at least 30&#xD;
             days since ending another investigational device or drug trial(s), unless in long-term&#xD;
             follow-up phase.&#xD;
&#xD;
         17. Use of hyperbaric oxygen therapy, prostanoids, spinal cord stimulation, lumbar&#xD;
             sympathectomy, wound dressing containing cells or growth factors, or topical platelet&#xD;
             derived growth factor.&#xD;
&#xD;
         18. Known allergies to any of the following: DMSO, human serum albumin, bovine serum&#xD;
             albumin.&#xD;
&#xD;
         19. History of allergic/hypersensitivity reaction to any substance having required&#xD;
             hospitalization and/or treatment with IV steroids/epinephrine.&#xD;
&#xD;
         20. Pulmonary disease requiring supplemental oxygen treatment on a daily basis.&#xD;
&#xD;
         21. Active malignancy or history of malignancy within 5 years prior to study entry.&#xD;
&#xD;
         22. In the opinion of the investigator, the subject is unsuitable for participating in the&#xD;
             study.&#xD;
&#xD;
         23. Chronic liver disease Child Pugh class B\C&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCI Medical Center 101 The City Drive S. Bldg 55 Rm 334 Orange, CA 92868</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center,LA,Beverly Hills,8536 Wilshire Boulevard, Third Floor</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Center ∣ Department of Surgery ∣ UC Davis Health 4860 Y street, Sacramento, CA suite #3400, 95817</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Center,Department of Surgery,UC Davis Health,4860 Y street</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Leonard M.Miller School of Medicine (UMMSM)-UHealth Pulmonary and Critical Care Medicine-Rosenstiel Building Location</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136-1015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Cardiac and Vascular Institute Baptist Health South Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center (TMC) (Tufts-New England Medical Center)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111-1552</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Room S3-746, Dept of Surgery, UMASS Medical School, 55 Lake Ave North.</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health Comprehensive Wound Healing Center</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai St. Luke's hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019-1147</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center,Durham,2424 Erwin Road Hock Plaza</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart Clinical Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Plastic Surgery ,Ut Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Virgin Mary&quot; EOOD,Clinic of Vascular Surgery</name>
      <address>
        <city>Burgas</city>
        <zip>8127</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Sveti Nokolay Chudotvorets EOOD - Lom,Surgery Department,Address 2, Todor Kableshkov str.</name>
      <address>
        <city>Lom</city>
        <zip>3600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;St. Georgi&quot; EAD,Clinic: Vascular Surgery and Angiology 66 &quot;Peshtersko Shosse&quot; Blvd., 8th floor, Hirurgicheski blok</name>
      <address>
        <city>Plovdiv</city>
        <zip>4001</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMBAL Kanev AD - Ruse,Department of Vascular Surgery Address: 2, Nezavisimost str</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Medica&quot; Ruse Department of Vascular Surgery 35, &quot;Riga&quot;, Str Post code: 7013 Ruse, Bulgaria</name>
      <address>
        <city>Ruse</city>
        <zip>7013</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT National Heart Hospital EAD,Clinic of Vascular Surgery and angiology</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Acibadem City Clinic MHAT Tokuda, Vascular Surgery and Angiology 51B &quot;Nikola Vaptzarov&quot; Blvd</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;St. Ekaterina&quot; EAD, Departement of Vascular Surgery</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cevni ambulance</name>
      <address>
        <city>Hodonín</city>
        <zip>69501</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angiologicka ambulance</name>
      <address>
        <city>Ostrava Dubina</city>
        <zip>700 30</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vseobecna Fakultni Nemocnice v Praze</name>
      <address>
        <city>Prague</city>
        <zip>12802</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intitute of Clinical and Experimental Medicine</name>
      <address>
        <city>Praha 4</city>
        <zip>140 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krajska zdravotni a.s., Masarykova nemocnice o.z.</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>40113</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Angiologie Universitätsklinikum Leipzig AöR Liebigstr. 20 04103 Leipzig, Germany</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medinos Klinikum Sonneberg Abteilung für Kardiologie/Angiologie - Studienambulanz Neustadter Straße 61 96515 Sonneberg Germany</name>
      <address>
        <city>Sonneberg</city>
        <state>Thueringen</state>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitats-Herzzentrum Freiburg</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Centrum fur Herz - Kreislauf - und Gefassmedizin - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Berlin-Buch, Klinik fur Angiologie</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf (UKD)</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St.Georg-Angiologische Ambulanz</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Kösching Krankenhausstr. 19, 85092 Kösching Germany</name>
      <address>
        <city>Kösching</city>
        <zip>85092</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48155</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz</name>
      <address>
        <city>Szekesfehervar</city>
        <state>Fejer</state>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szent Imre Egyetemi Oktato Korhaz</name>
      <address>
        <city>Budapest</city>
        <zip>1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flor Ferenc County Hospital</name>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>B-A-Z County and University Teaching Hospital</name>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josa Andras Megyei Korhaz</name>
      <address>
        <city>Nyíregyháza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem (PTE) Altalanos Orvostudomanyi Kar (AOK) (University of Pecs Medical School)</name>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blood Vessel Day Care at Clalit Community Horev Center, Horev Center</name>
      <address>
        <city>Haifa</city>
        <zip>3434119</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery Department, Hadassah Ein Karem MC</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery Department Rabin Medical Center Beilinson Hospital, 39 Jabotinski St. Petah Tikva Israel 4941492</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4941492</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cardiological Department, The Baruch Padeh Medical Center</name>
      <address>
        <city>Poriyya 'Illit</city>
        <zip>15208</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Acibadem Sistina Hospital,Thoracic and Vascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Re-Medika General Hospital,Cardiovascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Special Hospital for Surgical Diseases Zan Mitrev Clinic ,Cardiovascular Surgery</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cathedra and Clinic of Vascular Surgery and Angiology-Klinika Chirurgii Naczyniowej i Angiologii</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Specjalistyczny we Wroclawiu, Osrodek Badawczo-Rozwojowy,Intensywnego Nadzoru Kardlologleznego,</name>
      <address>
        <city>Wrocław</city>
        <zip>51-124</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Research Clinical Research Centre Beaufort Way Southmead Hospital Westbury on Trym Bristol</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hull And East Yorkshire Women And Children's Hospital-Hull And East Yorkshire Hospitals Nhs Trust</name>
      <address>
        <city>Hull</city>
        <zip>HU32JZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Vascular Research, St George's Hospital</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>North Macedonia</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Macedonia, The Former Yugoslav Republic of</country>
  </removed_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 27, 2016</study_first_submitted>
  <study_first_submitted_qc>December 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2016</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

